Bladder Cancer Clinical Trial
Official title:
Comparison of Nerve Stimulating Approach and Interfascial Injection Approach During Sono-guided Obturator Nerve Block in Transurethral Resection of Bladder Tumors Under Spinal Anesthesia
Transurethral resection of bladder tumor (TURB) has been essential treatment for bladder
tumours. Direct electrical stimulation of an obturator nerve during the TURB procedures can
trigger an inadvertent adductor muscle spasm, which can cause a serious complication like
bladder perforation.
General anesthesia with muscle relaxants for TURB does not guarantee a prevention of the
adductor muscle spasm. Spinal anesthesia with selective obturator nerve block (ONB) can be
an alternative anesthesia for TURB, but adductor spasm can also be induced because of
incomplete ONB. Recently, ultrasound guidance with nerve stimulator has been used to enhance
the safety, efficacy and shortening the onset time of ONB.
Some papers describe that comparable ONB can be done using ultrasound only without nerve
stimulator, in which there is a principle that obturator nerve runs along a given pathway.
Basically, obturator nerve is divided into two branches after exiting the obturator canal.
The anterior branch is located in the fascial planes among adductor longus, adductor brevis
and pectineus muscles, and the posterior branch is located between the adductor brevis and
adductor magnus muscles at the inguinal area. But it has been known that there are many
branching patterns of obturator nerve and high anatomic variability in the inguinal area in
a cadaver study. And subdivisions of obturator nerve in the inguinal area have been
described.
Therefore, this study was conducted to investigate the success rate of ultrasound-guided
obturator nerve block with interfascial injection approach group (US-IFI; experimental
group) was comparable to ultrasound-guided obturator nerve block with nerve stimulating
approach group (US-NS; control group) in TURB under spinal anesthesia. And we also evaluated
adductor muscle twitching patterns at the inguinal region when the ONB was performed.
After obtaining approval from the Gachon Gil Hospital Ethical Committee, written informed
consent was obtained from all patients anticipating TURB with American Society of
Anesthesiologists physical status (ASA) I or II. Sixty two patients anticipating
transurethral resection of the bladder tumors (TURB) under spinal anesthesia were enrolled
in this randomized controlled trial from December 2014 to May 2015. Exclusion criteria
included patients with diabetes or peripheral neuropathy; motor or sensory deficits in the
lower extremities, ASA greater than III, coagulation disorders, anticoagulant medication,
known allergy to local anesthetics, contraindications for spinal anesthesia (infection at
injection site, severe scoliosis or fusion operation), uncooperative patients and patients'
refusal. Routine monitoring was begun and Spinal anesthesia with hyperbaric 0.5% bupivacaine
12-15 mg was performed to reach the level of anesthesia, at least T10 to T4 in all patients.
Patients were then randomized into 1 of 2 groups (US-NS vs US-IFI) to receive ONB in the
inguinal crease level. Randomization was performed by a computer-generated random numbers
table. We counted one side obturator nerve as one, the number. Whether the right or left ONB
was done, was decided by surgeon according to the tumor location. If obturator block was
done in both sides, let it belong to the same group, and we counted it as two, the number.
Patients were then positioned supine, and the affected leg was slightly abducted and rotated
externally without knee flexion, and the inguinal region was prepared with a povidone iodine
solution. The 10 MHz linear probe (Zonare Medical Systems, California, USA) equipped with a
sterile plastic cover and gel. The transducer was positioned parallel to the inguinal crease
with 90° to the skin with the image depth of 4-5 cm. The inguinal region was examined
laterally from the femoral vein until the 3 muscle layers consisting of the adductor longus,
adductor brevis, and adductor magnus were identified with pectineus muscle medially along
the inguinal crease. We allowed transducer tilting cranially 0°-20° angle until a fascial
planes of the pectineus and adductor muscles were identified. A thick hyperechoic fascia was
used as a targeting landmark for ONB, not focus on the obturator nerve itself (One between
adductor longus and adductor brevis muscles for anterior branch, another between adductor
brevis and adductor magnus muscles for posterior branch of obturator nerve). We excluded the
case, in which three muscle layers were not identified definitely within the range.
In the US-NS group, 22-gauge, 120-mm stimulating needle (Stimuplex insulated needle; D Plus
B. Braun, Melsungen, Germany) attached to a nerve stimulator (Stimuplex HNS12;B. Braun,
Melsungen, Germany) advanced via an ultrasound in-plane approach from lateral to medical
direction to position the needle tip on the anterior branch. The nerve stimulator was then
turned on, and the stimulation current started at 0.5 mA. If adductor muscle twitching was
observed on the sonogram even at the stimulation current 0.3mA, 10mL of local anesthetics
(LA; 1.5% lidocaine + epi 1:200,000) were slowly injected within the muscle interface after
negative aspiration, resulting in separation of these two muscles under real-time
visualization. If there was misdistribution of LA spread (eg, spread into the muscle
tissue), the needle was redirected until the correct spread of LA was visualized. The needle
was withdrawn to the skin and reinserted to position the needle tip on the posterior branch.
The stimulation current started at 0.5 mA. If adductor muscle twitching was visualized on
the sonogram even at 0.3mA, another 5mL of LA was injected. After injection to the anterior
and posterior branch, the stimulation current increased 1.0 mA, and needle was re-advanced
as like Fig 1d for searching the residual muscle twitching. If muscle twitching was
observed, then current was decreased to 0.5 mA, and confirming the muscle twitching on the
sonogram at that current, 5ml of LA injected. We wrote that muscle twitching was occurred in
what kind of muscles or fascias.
In the US-IFI group, 22-gauge, 120-mm stimulating needle (Stimuplex insulated needle; D Plus
B. Braun, Melsungen, Germany) without nerve stimulator advanced via an ultrasound in-plane
approach from lateral to medical direction to position the needle tip on anterior branch.
After negative aspiration, 10mL of LA were slowly injected within the muscle interface,
resulting in separation of these two muscles under real-time visualization. The needle was
withdrawn to the skin and reinserted to position the needle tip on posterior branch, another
5mL of LA was injected. After that, the needle was withdrawn to the skin and reinserted to
the same spots, attached with nerve stimulator at the stimulation current 1.0 mA for
confirming the block of anterior and posterior branch. If adductor muscle twitching was
shown on sonogram, another 5mL of LA was injected, and it was documented as 'fail'. After
that, needle was re-advanced as like US-NS group for searching the residual muscle
twitching. It then went through the same process as the US-NS group, and we wrote that
muscle twitching was occurred in what kind of muscles or fascias. We used only the nerve
stimulator for confirming the success or fail of the ONB before the TURB surgery.
Any needle redirection after withdrawing to the skin, was recorded as an additional needle
pass. Before the injection, the image was captured as static, and the depth of anterior and
posterior branch was measured by use of the built-in caliper of the ultrasound machine. We
recorded ONB time, and time from the start of the sonographic examination until muscle
layers identification was included. All blocks were performed by one anesthesiologist with
more than 60 ONB experiences.
After performing the ONB, patients were positioned in lithotomy position. Endoscopic
resection of the neoplasm was started using a bipolar resectoscope (electrical current: 280
W) and endovesical irrigation with a normal saline solution. The surgery was performed by
six surgeons randomly. We requested two assistants of urology, who didn't know the study
groups (US-NS vs US-IFI) for obturator reflex grading. Obturator reflex grade was assessed
by the scale of Lee's paper. Gr I: no movement or palpable muscle twitching, Gr II: palpable
muscle twitching without movement, Gr III: slight movement of the thigh not interfering with
the surgical procedure, and Gr IV: vigorous movement interfering with the surgical
procedure.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT06034015 -
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of APL-1501 Extended Release (ER) Capsules Compared to APL-1202 Immediate Release (IR) Tablets in Healthy Volunteers
|
Phase 1 | |
| Recruiting |
NCT04235764 -
En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device
|
||
| Completed |
NCT02371447 -
VPM1002BC in Recurrent Non-muscle Invasive Bladder Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT04081246 -
Transurethral Modified En Bloc Resection For Large Bladder Tumours.
|
N/A | |
| Recruiting |
NCT06059547 -
Neoadjuvant Immunotherapy in Combination With the Anti-GDF-15 Antibody Visugromab (CTL-002) for Treatment of Muscle Invasive Bladder Cancer
|
Phase 2 | |
| Terminated |
NCT04779489 -
Checkpoint Inhibitor and Radiation Therapy in Bulky, Node-Positive Bladder Cancer
|
N/A | |
| Not yet recruiting |
NCT04493489 -
Propranolol Adjuvant Treatment of Bladder Cancer
|
Phase 2 | |
| Completed |
NCT03520231 -
Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases
|
Phase 2 | |
| Recruiting |
NCT04537221 -
Nordic Cystectomy Study III - Transfusion
|
||
| Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
| Completed |
NCT01955408 -
Severity of Overactive Bladder Symptoms in Patients After Synergo Treatment
|
N/A | |
| Completed |
NCT04487457 -
Prospective Study to Evaluate the Blood Kinetics of Immune Cells and Immunosuppressive Cytokines After Exposure to an Immunity Checkpoint Inhibitor (ICI): Study of the Impact of Chemotherapy
|
||
| Active, not recruiting |
NCT04383210 -
Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors
|
Phase 2 | |
| Recruiting |
NCT05562791 -
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer
|
Phase 1 | |
| Completed |
NCT00199849 -
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
|
Phase 1 | |
| Completed |
NCT02781428 -
To Detect the Sensitivity of the UroMark Assay
|
||
| Recruiting |
NCT04738630 -
Study of HX008 for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer
|
Phase 2 | |
| Completed |
NCT03980041 -
Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275)
|
Phase 2 | |
| Active, not recruiting |
NCT03978624 -
Window of Opportunity Study of Pembrolizumab Alone and in Combinations in Bladder Cancer
|
Phase 2 | |
| Completed |
NCT04534309 -
Behavioral Weight Loss Program for Cancer Survivors in Maryland
|
N/A |